H. Lundbeck A/S (HLBBF)
OTCMKTS · Delayed Price · Currency is USD
6.10
-0.13 (-2.09%)
At close: Feb 5, 2026
H. Lundbeck Revenue
In the year 2025, H. Lundbeck had annual revenue of 24.63B DKK with 11.93% growth. H. Lundbeck had revenue of 6.09B in the quarter ending December 31, 2025, with 9.96% growth.
Revenue
24.63B DKK
Revenue Growth
+11.93%
P/S Ratio
1.55
Revenue / Employee
4.89M DKK
Employees
5,039
Market Cap
5.99B USD
Revenue Chart
* This company reports financials in DKK.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 24.63B | 2.63B | 11.93% |
| Dec 31, 2024 | 22.00B | 2.09B | 10.51% |
| Dec 31, 2023 | 19.91B | 1.67B | 9.13% |
| Dec 31, 2022 | 18.25B | 1.95B | 11.95% |
| Dec 31, 2021 | 16.30B | -1.37B | -7.77% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sofgen Pharma | 423.75M |
| Jushi Holdings | 260.43M |
| Glass House Brands | 196.17M |
| MariMed | 157.38M |
| Elite Pharmaceuticals | 122.89M |
| Earth Science Tech | 33.84M |
| Radnostix | 14.07M |
| Healthy Extracts | 3.59M |
H. Lundbeck News
- 7 days ago - H. Lundbeck A/S 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 7 days ago - H. Lundbeck A/S (HLBBF) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - H. Lundbeck AS (HLUBF) Full Year 2025 Earnings Call Highlights: Record Growth and Strategic Advances - GuruFocus
- 2 months ago - ALKS Raises Its Offer to Buy Avadel In Response to Lundbeck's Proposal - Nasdaq
- 3 months ago - Alkermes Ups Its Avadel Bid To $2.37 Billion In A Buyout Battle With Lundbeck - Investor's Business Daily
- 3 months ago - Alkermes raises Avadel buyout offer after Lundbeck’s unsolicited bid - Seeking Alpha
- 3 months ago - Avadel Board Labels Lundbeck Acquisition Bid a Superior Proposal - Nasdaq
- 3 months ago - Avadel Board of Directors Declares Lundbeck Proposal a "Company Superior Proposal" - Benzinga